当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析

万泰生物

(603392)

  

流通市值:358.08亿  总市值:358.08亿
流通股本:12.64亿   总股本:12.64亿

万泰生物(603392)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.45亿元,每股收益-0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1198818.56万元,未分配利润679062.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1376099.68万元,负债177281.12万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入523,344,880.881,818,967,457.871,498,369,947.13843,561,860.09
营业总成本518,061,923.752,322,416,853.651,780,002,318.881,020,748,464.07
其他经营收益
营业利润-58,681,752.57-469,223,782.37-184,441,733.74-139,343,509.3
利润总额-59,869,690.47-480,885,756.41-191,856,422.75-145,682,857.91
净利润-44,887,263.69-413,963,529.44-173,891,354.56-145,492,229.78
每股收益
其他综合收益----
综合收益总额-44,887,263.69-413,963,529.44-173,891,354.56-145,492,229.78
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,730,935,816.057,526,044,987.117,991,912,888.337,902,103,469.5
非流动资产:
非流动资产合计7,030,061,031.76,518,011,864.186,378,844,898.656,338,402,587.52
资产总计13,760,996,847.7514,044,056,851.2914,370,757,786.9814,240,506,057.02
流动负债:
流动负债合计1,598,064,895.991,802,229,693.251,873,989,314.31,726,115,381.98
非流动负债:
非流动负债合计174,746,322.81208,754,265.39223,623,405.15211,923,039.05
负债合计1,772,811,218.792,010,983,958.642,097,612,719.451,938,038,421.03
所有者权益(或股东权益):
归属于母公司股东权益合计11,821,624,431.1511,864,608,261.8812,089,453,978.5212,118,763,891.64
股东权益合计11,988,185,628.9612,033,072,892.6512,273,145,067.5312,302,467,635.99
负债和股东权益合计13,760,996,847.7514,044,056,851.2914,370,757,786.9814,240,506,057.02
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计477,044,634.292,578,952,453.091,921,052,958.151,169,621,581.5
经营活动现金流出小计709,088,870.922,489,198,409.991,913,768,403.481,236,174,987.06
经营活动产生的现金流量净额-232,044,236.6389,754,043.17,284,554.67-66,553,405.56
投资活动产生的现金流量:
投资活动现金流入小计3,623,256,933.714,978,263,799.474,087,759,401.772,268,024,732.15
投资活动现金流出小计3,307,708,931.65,737,272,531.464,164,756,502.092,767,383,684.44
投资活动产生的现金流量净额315,548,002.11-759,008,731.99-76,997,100.32-499,358,952.29
筹资活动产生的现金流量:
筹资活动现金流入小计67,369,965.82343,558,490.81251,925,755.55120,598,537.5
筹资活动现金流出小计60,110,989.4343,086,830.2240,742,040.19167,381,109.66
筹资活动产生的现金流量净额7,258,976.42471,660.6111,183,715.36-46,782,572.16
汇率变动对现金及现金等价物的影响-12,590,723.87-13,270,093.55-4,670,237.65-891,741.35
现金及现金等价物净增加额78,172,018.03-682,053,121.83-63,199,067.94-613,586,671.36
期末现金及现金等价物余额1,423,124,722.71,344,952,704.671,963,806,758.561,413,419,155.14
补充资料:
现金及现金等价物的净增加额--682,053,121.83--613,586,671.36
TOP↑